Oncopeptides AB Net Asset Quality Index

Latest as of December 2025: -43.7%

Oncopeptides AB net asset quality index. Oncopeptides AB (ONCO) has a Net Asset Quality Index of -43.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr134.84 Million minus total liabilities of Skr193.73 Million yields net assets of Skr-58.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Oncopeptides AB's book value for net asset value and shareholders' equity analysis.

Quality Index

-43.7%
Equity / Total Assets

Net Assets

Skr-58.89 Million
SEK

Total Assets

Skr134.84 Million
SEK

Total Liabilities

Skr193.73 Million
SEK

Net Asset Quality Index of Oncopeptides AB (2014–2025)

Net asset quality index of Oncopeptides AB from 2014 to 2025. This chart shows how Oncopeptides AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at -43.7%, representing net assets of Skr-58.89 Million against total assets of Skr134.84 Million SEK. Check Oncopeptides AB strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Oncopeptides AB Net Asset Quality Index by Year (2014–2025)

Oncopeptides AB net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Oncopeptides AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Oncopeptides AB worth.

Year Quality Index Net Assets (SEK) Total Assets Total Liabilities Change (pp)
2025 -43.7% Skr-58.89 Million Skr134.84 Million Skr193.73 Million ▼ -65.9 pp
2024 22.2% Skr54.28 Million Skr244.19 Million Skr189.91 Million ▼ -1.6 pp
2023 23.8% Skr56.78 Million Skr238.38 Million Skr181.60 Million ▼ -52.6 pp
2022 76.4% Skr294.29 Million Skr385.32 Million Skr91.03 Million ▲ +28.4 pp
2021 48.0% Skr210.87 Million Skr439.38 Million Skr228.51 Million ▼ -12.9 pp
2020 60.9% Skr576.90 Million Skr946.76 Million Skr369.86 Million ▼ -19.3 pp
2019 80.2% Skr797.01 Million Skr993.49 Million Skr196.47 Million ▲ +9.2 pp
2018 71.0% Skr315.83 Million Skr444.53 Million Skr128.70 Million ▼ -16.1 pp
2017 87.1% Skr418.00 Million Skr479.82 Million Skr61.82 Million ▲ +39.8 pp
2016 47.3% Skr26.34 Million Skr55.63 Million Skr29.30 Million ▲ +106.4 pp
2015 -59.1% Skr-2.60 Million Skr4.40 Million Skr7.00 Million ▼ -117.0 pp
2014 58.0% Skr7.61 Million Skr13.12 Million Skr5.52 Million —
pp = percentage points